Global Cancer Technology, Inc.
PrivateLast Round
Crowdfunding
Aug 1, 2026
Est. Valuation
$27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Global Cancer Technology, Inc. is a biopharmaceutical company that develops innovative cancer treatments, including small-molecule PI3K inhibitors and remote-controlled drug delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Global Cancer Technology, Inc. Comparables
Compare Global Cancer Technology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kazia Therapeutics | 78% | |
| Gibson Oncology, LLC | 78% | |
| PDX Pharmaceuticals | 77% | |
Global Cancer Technology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 1, 2026 | ||||
| VC Round | Jun 2, 2021 | ||||
| Private Placement | Jun 2, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Raised capital via crowdfunding.
- Apr 9, 2026
Monthly visitors increased 117% MoM.
Global Cancer Technology, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Global Cancer Technology, Inc.'s valuation, stock price, and market status.